| 1.4 |
6.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.2 |
3.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.0 |
3.0 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.0 |
2.9 |
GO:1902071 |
positive regulation of cellular response to hypoxia(GO:1900039) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.9 |
3.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.8 |
3.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.7 |
2.1 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.6 |
2.5 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.6 |
4.3 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.6 |
3.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 |
2.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.5 |
3.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
1.4 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.4 |
2.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.4 |
1.5 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 |
2.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
2.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
0.9 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
0.9 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.3 |
2.0 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 |
2.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.3 |
6.3 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.3 |
1.4 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.3 |
1.8 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
1.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.9 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 |
1.1 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.2 |
0.6 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
0.6 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.2 |
1.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
0.6 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
1.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.2 |
1.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.2 |
0.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
0.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.2 |
1.8 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.0 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
1.1 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.2 |
0.5 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 |
0.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
1.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
4.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.5 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.8 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
1.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
1.7 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.6 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.7 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
2.8 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.9 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.1 |
0.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.1 |
0.7 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
3.2 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.4 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
1.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.4 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
0.9 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.4 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.1 |
1.8 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.8 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.7 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.4 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.0 |
1.7 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.2 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.0 |
0.2 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.0 |
0.5 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.7 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.8 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.6 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
1.0 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.9 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.2 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.3 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
1.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.3 |
GO:0048733 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) sebaceous gland development(GO:0048733) |
| 0.0 |
0.6 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.4 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.4 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.2 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
1.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.8 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.5 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.9 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
1.0 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.0 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.4 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
1.4 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.7 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.0 |
1.6 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.0 |
1.4 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
